Concepedia

Publication | Open Access

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

601

Citations

28

References

2017

Year

References

YearCitations

Page 1